Back to
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
AERI17 quarters
Position history for
CHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in AERIE PHARMACEUTICALS INC
As of its Q3 2022 13F, Charles Schwab Investment Management held 355,296 shares of AERI (Aerie Pharmaceuticals), worth $5.4M. Charles Schwab Investment Management's 13F filings listed AERI from Q4 2018 to Q3 2022, 16 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$7.4M
Total Shares Change
-205,886
Quarter-by-Quarter History
Other major holders of AERI: WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C.